Volume 19, Issue 10, Pages (October 2011)

Slides:



Advertisements
Similar presentations
The Structure of a Bcl-xL/Bim Fragment Complex
Advertisements

Volume 14, Issue 1, Pages (January 2008)
Volume 129, Issue 6, Pages (June 2007)
Volume 2, Issue 3, Pages (September 2002)
Glen S. Cho, Jack W. Szostak  Chemistry & Biology 
Sebastian Meyer, Raimund Dutzler  Structure 
Volume 125, Issue 1, Pages (April 2006)
Volume 40, Issue 3, Pages (November 2010)
Structural Basis for Vertebrate Filamin Dimerization
The Structure of the Cytoplasmic Domain of the Chloride Channel ClC-Ka Reveals a Conserved Interaction Interface  Sandra Markovic, Raimund Dutzler  Structure 
Identification of Phe187 as a Crucial Dimerization Determinant Facilitates Crystallization of a Monomeric Retroviral Integrase Core Domain  Meytal Galilee,
Volume 123, Issue 5, Pages (December 2005)
Callum Smits, Peter E. Czabotar, Mark G. Hinds, Catherine L. Day 
Volume 23, Issue 1, Pages (January 2015)
The BCL-2 Family Reunion
Volume 12, Issue 2, Pages (August 2007)
X-Ray Crystallography and Electron Microscopy of Cross- and Multi-Module Nonribosomal Peptide Synthetase Proteins Reveal a Flexible Architecture  Michael.
Volume 8, Issue 3, Pages (September 2001)
Chen-Chou Wu, William J. Rice, David L. Stokes  Structure 
Volume 19, Issue 9, Pages (September 2011)
Dimers Probe the Assembly Status of Multimeric Membrane Proteins 
Volume 16, Issue 5, Pages (December 2004)
Volume 64, Issue 3, Pages (November 2016)
Volume 24, Issue 3, Pages (March 2016)
Volume 18, Issue 8, Pages (August 2010)
Volume 135, Issue 6, Pages (December 2008)
Structure of the Angiopoietin-2 Receptor Binding Domain and Identification of Surfaces Involved in Tie2 Recognition  William A. Barton, Dorothea Tzvetkova,
Structure and T Cell Inhibition Properties of B7 Family Member, B7-H3
Volume 30, Issue 3, Pages (May 2008)
Crystal Structure of Tetrameric Arabidopsis MYC2 Reveals the Mechanism of Enhanced Interaction with DNA  Teng-fei Lian, Yong-ping Xu, Lan-fen Li, Xiao-Dong.
Volume 17, Issue 4, Pages (April 2009)
Volume 14, Issue 1, Pages (January 2008)
Volume 18, Issue 5, Pages (May 2010)
Phospho-Pon Binding-Mediated Fine-Tuning of Plk1 Activity
Leslie J. Bannon, Betty L. Cabrera, Kathleen J. Green 
Coiled Coils Direct Assembly of a Cold-Activated TRP Channel
Volume 55, Issue 6, Pages (September 2014)
Bax Activation and Induction of Apoptosis in Human Keratinocytes by the Protein Kinase C δ Catalytic Domain  Leonid A. Sitailo, Shalini S. Tibudan, Mitchell.
Colin Kwok, Bernd B. Zeisig, Shuo Dong, Chi Wai Eric So  Cancer Cell 
Selective Dimerization of a C2H2 Zinc Finger Subfamily
Volume 26, Issue 1, Pages e4 (January 2018)
Volume 2, Issue 3, Pages (September 2002)
Structural Basis for Vertebrate Filamin Dimerization
Volume 14, Issue 4, Pages (April 2006)
Volume 16, Issue 3, Pages (March 2008)
Volume 22, Issue 12, Pages (December 2014)
Volume 17, Issue 3, Pages (February 2005)
Volume 36, Issue 3, Pages (November 2009)
Volume 16, Issue 8, Pages (August 2008)
Coiled-Coil Domains of SUN Proteins as Intrinsic Dynamic Regulators
Volume 21, Issue 1, Pages (January 2013)
Volume 21, Issue 7, Pages (July 2013)
Paolo A. Lobo, Lynn Kimlicka, Ching-Chieh Tung, Filip Van Petegem 
Scarlet S. Shell, Christopher D. Putnam, Richard D. Kolodner 
Volume 26, Issue 1, Pages (April 2007)
Volume 12, Issue 1, Pages (July 2015)
Volume 17, Issue 8, Pages (August 2009)
Nina C. Leksa, Stephen G. Brohawn, Thomas U. Schwartz  Structure 
Volume 111, Issue 3, Pages (November 2002)
Volume 24, Issue 3, Pages (March 2016)
Volume 8, Issue 3, Pages (September 2001)
Volume 14, Issue 3, Pages (March 2006)
Transcriptional Regulation by p53 through Intrinsic DNA/Chromatin Binding and Site- Directed Cofactor Recruitment  Joaquin M Espinosa, Beverly M Emerson 
Volume 9, Issue 1, Pages (January 2002)
A Stapled BID BH3 Helix Directly Binds and Activates BAX
Hybrid Structural Model of the Complete Human ESCRT-0 Complex
Sabine Pokutta, William I. Weis  Molecular Cell 
Volume 36, Issue 4, Pages (November 2009)
Jörg Hartkamp, Brian Carpenter, Stefan G.E. Roberts  Molecular Cell 
Volume 63, Issue 3, Pages (August 2016)
Presentation transcript:

Volume 19, Issue 10, Pages 1467-1476 (October 2011) Crystal Structure of a BCL-W Domain-Swapped Dimer: Implications for the Function of BCL-2 Family Proteins  Erinna F. Lee, Grant Dewson, Brian J. Smith, Marco Evangelista, Anne Pettikiriarachchi, Con Dogovski, Matthew A. Perugini, Peter M. Colman, W. Douglas Fairlie  Structure  Volume 19, Issue 10, Pages 1467-1476 (October 2011) DOI: 10.1016/j.str.2011.07.015 Copyright © 2011 Elsevier Ltd Terms and Conditions

Figure 1 BCL-W ΔC but Not BCL-2 ΔC Forms a Dimer (A) Preparative gel filtration chromatography of BCL-W and BCL-2 on a Superdex 75 16/60 column. BCL-W elutes as two peaks (labeled 1 and 2). Peak 1 elutes at a volume consistent with a dimer (∼40 kDa) whereas Peak 2 has an elution volume consistent with a monomer. The ratio of dimer/monomer varies between preparations ranging from ∼5:1 as shown, to 1:1. BCL-2 always elutes as a monomer when purified in the same manner. (B) Sedimentation velocity analysis using an analytical ultracentrifuge confirms that Peak 1 and Peak 2 represent dimeric and monomeric forms of BCL-W respectively. (C) The stability of the BCL-W dimer was analyzed by gel-filtration chromatography (Superdex 75 10/300 column) following storage at either 4°C or room temperature (RT) for the indicated times. Structure 2011 19, 1467-1476DOI: (10.1016/j.str.2011.07.015) Copyright © 2011 Elsevier Ltd Terms and Conditions

Figure 2 Crystal Structure of BCL-W ΔC Dimmer (A) The BCL-W dimer (protomers in green and blue) involves a domain swap of helices α3 and α4. (B) Overlay of one protomer from the dimer (blue) with the NMR structure of the BCL-W monomer (PDB: 10OL) (pink). The structures are essentially identical except for helices α3 and α4. (C) Overlay of the “binding groove” from one protomer of the BCL-W dimer (red) with the NMR structure of BCL-W monomer (pink with “groove” in yellow) reveals a somewhat different orientation relative to the protein core. (D) The BCL-W dimer has a 10 Å pore-shaped tunnel co-incident with the dimer dyad axis. See also Figure S1. Structure 2011 19, 1467-1476DOI: (10.1016/j.str.2011.07.015) Copyright © 2011 Elsevier Ltd Terms and Conditions

Figure 3 BH3 Peptides from BIM, and to a Lesser Extent PUMA, Converts BCL-W ΔC Dimer to a Tetramer (A) ITC analysis of BCL-W dimer and BCL-W monomer binding to a synthetic peptide corresponding to the BAD BH3 domain. The stoichiometry for the dimer/peptide interaction is 0.5:1 whereas for the monomer/peptide interaction is 1:1. (B) Negligible binding to a NOXA BH3 peptide is observed for both the dimer and monomer as analyzed by ITC. (C) The effect of treatment of BCL-W dimer with various BH3 peptides was assessed by gel-filtration chromatography. The protein was incubated with each peptide at a 2-fold molar excess for 1 hr at room temperature prior to injection on a gel-filtration column (Superdex 75 10/300). Only BIM, and to a lesser extent PUMA, have an effect on the oligomeric state of the protein, converting it to a tetramer as assessed by analytical ultracentrifugation. (D) Sedimentation velocity analysis using an analytical ultracentrifuge confirms that the higher molecular weight form of BCL-W that is generated following incubation with BIM BH3 peptide is a tetramer. BCL-W monomer and dimer samples were included as controls. Structure 2011 19, 1467-1476DOI: (10.1016/j.str.2011.07.015) Copyright © 2011 Elsevier Ltd Terms and Conditions

Figure 4 Functional Role of the α4-α5 Hinge in BCL-W (A) Preparative gel-filtration chromatography of BCL-W ΔC mutant (BCL-W mt) in which the α4-α5 hinge residues were replaced with the corresponding residues from BCL-2. This protein is consistently purified predominantly as a monomer. (B and C) Overexpression of full-length BCL-W rescues (B) mcl-1−/− MEFs from killing by ABT-737 and (C) wild-type MEFs by etoposide, although the mutated α4-α5 linker BCL-W construct is more potent. (D) Relatively less cytochrome c is released from the pellet fraction (P) containing mitochondria into the soluble fraction (S) in cells expressing the BCL-W hinge mutant compared to cells expressing wild-type BCL-W following treatment with BIM. (D) The increased potency of the BCL-W mutant occurs even though it is less well expressed than wild-type BCL-W. Data in (B) and (D) represent means ± SD (error bars) of three experiments. Structure 2011 19, 1467-1476DOI: (10.1016/j.str.2011.07.015) Copyright © 2011 Elsevier Ltd Terms and Conditions

Figure 5 Functional Role of the α4-α5 Hinge in BAK (A–C) Overexpression of BAK or BAK in which the α4-α5 hinge sequence is replaced with that from BCL-2 (BAK/2hinge) in bax−/−bak−/− MEFs makes them sensitive to (A) ultraviolet irradiation, (B) treatment with etoposide, or (C) overexpression of BIM, but replacement of the corresponding BCL-W hinge sequence (BAK/Whinge) renders it inactive. (D) Relative expression levels of HA tagged BAK and BAK hinge mutants in bax−/−bak−/− MEFs as determined by western blot. (E) The BAK/BCL-2 and BAK/BCL-W hinge mutants both localize to the membrane fraction (P) in cells, like wild-type BAK, as assessed by western blotting following digitonin permeabilization of bax−/−bak−/− MEFs expressing these proteins. S, soluble fraction. (F) Treatment of the membranes isolated from digitonin-permeabilized MEFs with tBID results in conversion of the majority of wild-type BAK or the BAK/2hinge mutant to a dimer whereas the BAK/Whinge mutant remains mostly monomeric, as assessed by Blue Native PAGE. (G) Addition of antibody 4B5 that binds the BAK BH3 domain together with tBID to membranes from cells expressing either BAK or hinge mutants enables their immunoprecipitation. However, addition of the antibody after treatment with tBID resulted in reduced immunoprecipitation of wild-type BAK and the BAK/2hinge mutant indicating that the 4B5 BH3 domain epitope was now shielded, whereas in the BAK/Whinge mutant, the BH3 domain remained exposed. The anti-BAK 7D10 antibody recognizes a distinct epitope to 4B5 and immunoprecipitated similar levels of BAK or BAK mutants regardless of whether it was added during or after tBID treatment. (H) Expression of wild-type or BAK hinge mutants in bax−/− cells increases their sensitivity to etoposide compared to cells transduced with a retrovirus derived from an empty vector. (I) Relative expression levels of HA tagged BAK and BAK hinge mutants in bax−/− MEFs as determined by western blot. Data in (A–C) and (H) represent means ± SD (error bars) of three experiments. Structure 2011 19, 1467-1476DOI: (10.1016/j.str.2011.07.015) Copyright © 2011 Elsevier Ltd Terms and Conditions